30 Day Trial
ORTHOKNOW logo

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Year in Review

2014 Revenue: Stryker

4Q14 revenue:

Orthopaedics $1,110MM, +5% (U.S. +7%)

  • Hips $331MM, +0.1% (U.S. +5%, ex-U.S. -5%)
  • Knees $363MM, flat (U.S. flat)
  • Trauma/Extremities $335MM, +13% (U.S. +19%; U.S. Foot/Ankle +25%)
  • Other $81MM, +13%

Endoscopy $390MM, +13%

Spine $192MM, -0.5%

  • Net sales grew by 5% due to increased unit volume and changes in product mix, negatively impacted by 3.3% in pricing
  • MAKO: sold 20 robots in 4Q (up from 8 in 3Q); procedure volume increased in double-digits YoY; submitted 510(k) for Triathlon knee in late 2014; targeting 2Q limited release of cementless uni knee and 2015 launch of Accolade hip and X3 poly bearings
  • Observing no impact from competitor strategy to sell recon direct to U.S. hospitals at discount
  • Reverse shoulder performing well in limited launch

 

2014 revenue:

Orthopaedics $4,153MM, +6%

  • Hips $1,291MM, +3% (U.S. +10%)
  • Knees $1,396MM, +3% (U.S. +8%)
  • Trauma/Extremities $1,230MM, +11%

Endoscopy $1,382MM, +14%

Spine $740MM, +0.3%